DRW Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-22,683
| Closed | -$637K | – | 1357 |
|
|
2026
Q1 | $637K | Sell |
22,683
-6,632
| -23% | -$177K | 0.01% | 504 |
|
|
2025
Q4 | $729K | Buy |
+29,315
| New | +$739K | 0.02% | 373 |
|
|
2025
Q2 | – | Sell |
-45,406
| Closed | -$1.15M | – | 1224 |
|
|
2025
Q1 | $1.15M | Buy |
45,406
+12,310
| +37% | +$322K | 0.03% | 245 |
|
|
2024
Q4 | $877K | Buy |
+33,096
| New | +$898K | 0.03% | 242 |
|
|
2024
Q2 | – | Sell |
-30,699
| Closed | -$852K | – | 604 |
|
|
2024
Q1 | $852K | Buy |
+30,699
| New | +$852K | 0.02% | 190 |
|
|
2023
Q4 | – | Sell |
-7,400
| Closed | -$245K | – | 421 |
|
|
2023
Q3 | $245K | Buy |
+7,400
| New | +$262K | 0.01% | 287 |
|
|
2023
Q2 | – | Sell |
-24,180
| Closed | -$987K | – | 428 |
|
|
2023
Q1 | $987K | Buy |
+24,180
| New | +$1.04M | 0.02% | 136 |
|
|
2022
Q4 | – | Sell |
-12,407
| Closed | -$543K | – | 324 |
|
|
2022
Q3 | $543K | Buy |
+12,407
| New | +$603K | 0.01% | 143 |
|
|
2022
Q2 | – | Sell |
-26,309
| Closed | -$1.36M | – | 330 |
|
|
2022
Q1 | $1.36M | Buy |
26,309
+11,256
| +75% | +$584K | 0.04% | 114 |
|
|
2021
Q4 | $889K | Buy |
+15,053
| New | +$746K | 0.03% | 101 |
|
|
2021
Q3 | – | Sell |
-18,193
| Closed | -$712K | – | 346 |
|
|
2021
Q2 | $712K | Buy |
+18,193
| New | +$707K | 0.02% | 153 |
|
|
2020
Q2 | – | Sell |
-8,420
| Closed | -$240K | – | 297 |
|
|
2020
Q1 | $240K | Buy |
+8,420
| New | +$287K | 0.01% | 232 |
|
|
2018
Q1 | – | Sell |
-88,055
| Closed | -$3.03M | – | 407 |
|
|
2017
Q4 | $3.03M | Buy |
+88,055
| New | +$3M | 0.32% | 43 |
|
|
2016
Q2 | – | Sell |
-11,288
| Closed | -$317K | – | 89 |
|
|
2016
Q1 | $317K | Sell |
11,288
-109,922
| -91% | -$3.14M | 0.02% | 62 |
|
|
2015
Q4 | $3.71M | Buy |
121,210
+26,350
| +28% | +$829K | 0.37% | 12 |
|
|
2015
Q3 | $2.83M | Buy |
+94,860
| New | +$3.04M | 0.31% | 13 |
|
|
2013
Q3 | – | Sell |
-73,094
| Closed | -$1.94M | – | 228 |
|
|
2013
Q2 | $1.94M | Buy |
+73,094
| New | +$2.02M | 0.07% | 54 |
|
Other funds holding PFE
DRW Securities's PFE Position: Q2 2026 in Review
DRW Securities sold out of Pfizer (PFE) in Q2 2026, closing a stake of 22,683 shares — an estimated $637K sold.
DRW Securities first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $3.71M in Q4 2015. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- DRW Securities reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- DRW Securities sold 22,683 Pfizer shares in Q2 2026, an estimated $637K.
- DRW Securities first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
- DRW Securities's Pfizer position peaked at $3.71M in Q4 2015.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.